Table 2.
Linear regression analysis between clinical disease activity variables and immuno-nutritional indexes and SLEDAI and SDI scores.
| SLEDAI Score | SDI Score | |||||
|---|---|---|---|---|---|---|
| β | 95% CI | p Value | β | 95% CI | p Value | |
| hsCRP (mg/dL) | 0.116 | 0.023, 0.209 | 0.015 | 0.083 | 0.041, 0.124 | <0.001 |
| Anti-dsDNA (IU/mL) | −1.201 | −2.467, 0.065 | 0.063 | −0.712 | −1.302, −0.121 | 0.018 |
| Complement C3 level (mg/dL) | −0.008 | −0.023, 0.006 | 0.264 | 0.010 | 0.004, 0.017 | 0.002 |
| Complement C4 level (mg/dL) | −0.039 | −0.070, −0.007 | 0.017 | 0.009 | −0.015, 0.015 | 0.963 |
| WBC count (μL) | −0.197 | −0.394, −0.001 | 0.049 | 0.036 | −0.055, 0.128 | 0.432 |
| Platelet count (×1000/(μL) | 0.000 | −0.006, 0.005 | 0.981 | −0.001 | −0.004, 0.001 | 0.241 |
| PNI | −0.176 | −0.254, −0.098 | <0.001 | −0.020 | −0.058, 0.018 | 0.307 |
| CONUT | 0.168 | −0.100, 0.436 | 0.218 | 0.013 | 0.111, 0.137 | 0.834 |
| NRI | 0.056 | 0.019, 0.093 | 0.003 | 0.047 | 0.031, 0.063 | <0.001 |
Adjusted for age, sex and medical treatment (immunosuppressants, antimalarials and/or corticosteroids). hs-CRP, high-sensitivity C-reactive protein; Anti-dsDNA, anti-double stranded DNA antibodies; WBC, white blood cells; PNI, prognostic nutritional index; CONUT, controlling nutritional status; NRI, nutritional risk index.